Vector Futures

Vector Futures Ltd is a synthetic biology company focused on accelerating innovation in synthetic biology and genetic technologies. Its mission is to help clients explore the wide range of possible biological variants using AI-guided genetic engineering. The company provides contract research services to support the discovery, development, and validation of biological products at all technology readiness levels.

Its work spans genetic therapies, including viral and non-viral vectors and gene editing, as well as synthetic biology services such as DNA and mRNA synthesis, bioinformatics, and AI-directed evolution. For biologics, Vector Futures offers expertise in CAR-T constructs, antibody engineering, cell line development, process development, manufacturing feasibility studies, and potency assays.

Service packages cover product discovery, including technology creation, AI-based design, and selection of promising variants; product development, including optimization and directed evolution; and product validation, including feasibility demonstrations and data to support intellectual property or fundraising. Vector Futures reports 13 years of experience, more than £7 million in funding raised, and over 50 research publications. It is based in London, United Kingdom.